Compare FKWL & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | FKWL | MDCX |
|---|---|---|
| Founded | 1981 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | |
| Sector | Utilities | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 53.5M | 53.4M |
| IPO Year | 1996 | N/A |
| Metric | FKWL | MDCX |
|---|---|---|
| Price | $4.53 | $1.89 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $6.00 | ★ $23.50 |
| AVG Volume (30 Days) | 11.6K | ★ 362.6K |
| Earning Date | 11-14-2025 | 11-14-2025 |
| Dividend Yield | ★ 0.88% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $45,508,949.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $13.49 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 32.05 | N/A |
| 52 Week Low | $3.67 | $1.68 |
| 52 Week High | $7.45 | $8.94 |
| Indicator | FKWL | MDCX |
|---|---|---|
| Relative Strength Index (RSI) | 44.81 | 42.45 |
| Support Level | $4.41 | $1.68 |
| Resistance Level | $4.65 | $2.25 |
| Average True Range (ATR) | 0.14 | 0.19 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 58.81 | 35.54 |
Franklin Wireless Corp is a provider of wireless solutions, including mobile hotspots, routers, and modems, as well as hardware and software products that support machine-to-machine (M2M) applications and the Internet of Things (IoT). Its M2M and IoT solutions include embedded modules, modems, and gateways built to deliver reliable always-on connectivity supporting a spectrum of applications. These products are designed to solve wireless connectivity challenges in a range of vertical markets, including video surveillance, digital signage, home security, oil and gas exploration, kiosks, fleet management, smart grid, vehicle diagnostics, and telematics.
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.